Clinical trial / 2013
Brewer's yeast supplementation significantly improved fasting blood sugar, HbA1c, and insulin sensitivity in adults with type 2 diabetes.
In a randomized double-blind controlled trial, 84 adults with type 2 diabetes were assigned to receive either brewer's yeast (1800 mg/day as six 300 mg tablets) or a placebo for 12 weeks. Changes in fasting blood sugar, glycosylated hemoglobin, and insulin sensitivity were significantly different between groups (P < 0.001, P < 0.001, and P = 0.02, respectively). Differences remained statistically significant at the end of the study after adjusting for baseline values (P = 0.002, P < 0.001, and P = 0.02). Changes in body mass index, 24-hour food record, and insulin resistance were not significant.
- Study type
- Randomized double-blind controlled clinical trial
- Who was studied
- 84 adults (21 men, 63 women) aged 46.3 ± 6.1 years with type 2 diabetes mellitus
- What was measured
- Fasting blood sugar, HbA1c, insulin sensitivity, insulin resistance, BMI, food consumption
THE PAPER
Brewer's Yeast Improves Glycemic Indices in Type 2 Diabetes Mellitus.
Hosseinzadeh P, Javanbakht MH, Mostafavi SA, Djalali M, Derakhshanian H, Hajianfar H, Bahonar A, Djazayery A. Int J Prev Med, 2013.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.